Mechanisms regulating vascular and lymphatic regeneration in the heart after myocardial infarction

• Published in: The Journal of pathology Vol. 260; no. 5; pp. 666 - 678
• Main Authors: Berkeley, Bronwyn, Tang, Michelle Nga Huen, Brittan, Mairi
• Format: Journal Article
• Language: English
• Published: Chichester, UK John Wiley & Sons, Ltd 01.08.2023; Wiley Subscription Services, Inc
• Subjects: Animals; cardiac regeneration; Cardiovascular diseases; Congestive heart failure; endothelial cells; Heart; Heart attacks; heart failure; Heart Failure - pathology; Humans; Infant, Newborn; Invited Review; Invited Reviews; Ischemia; lymphangiogenesis; Lymphatic Vessels - pathology; Mammals; Myocardial infarction; Myocardial Infarction - pathology; Neonates; neovascularisation; Regeneration; Reperfusion; Thrombosis; VEGF; heart failure; cardiac regeneration; endothelial cells; VEGF; myocardial infarction; lymphangiogenesis; neovascularisation
• ISSN: 0022-3417; 1096-9896; 1096-9896
• DOI: 10.1002/path.6093

Myocardial infarction, caused by a thrombus or coronary vascular occlusion, leads to irreversible ischaemic injury. Advances in early reperfusion strategies have significantly reduced short‐term mortality after myocardial infarction. However, survivors have an increased risk of developing heart failure, which confers a high risk of death at 1 year. The capacity of the injured neonatal mammalian heart to regenerate has stimulated extensive research into whether recapitulation of developmental regeneration programmes may be beneficial in adult cardiovascular disease. Restoration of functional blood and lymphatic vascular networks in the infarct and border regions via neovascularisation and lymphangiogenesis, respectively, is a key requirement to facilitate myocardial regeneration. An improved understanding of the endogenous mechanisms regulating coronary vascular and lymphatic expansion and function in development and in adult patients after myocardial infarction may inform future therapeutic strategies and improve translation from pre‐clinical studies. In this review, we explore the underpinning research and key findings in the field of cardiovascular regeneration, with a focus on neovascularisation and lymphangiogenesis, and discuss the outcomes of therapeutic strategies employed to date. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.